Meningo A&C Injection
Prescription Required
Product introduction
Meningo A&C Injection is used to prevent meningococcal disease. This is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
Meningo A&C Injection is used to prevent some infectious diseases
Meningo A&C Injection is used to prevent some infectious diseases
Uses of Meningo A&C Injection
Benefits of Meningo A&C Injection
In Prevention of Meningococcal disease
Meningo A&C Injection is a vaccine that helps protect against meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in children (from 2 years of age), adolescents and adults. It is given by a doctor or a nurse and should not be self-administered. Consult your doctor if you have any doubts. Keeping up to date with recommended vaccines is the best defense against meningococcal disease. Maintaining healthy habits, like getting plenty of rest and not having close contact with people who are sick, is also helpful in preventing it.
Side effects of Meningo A&C Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Meningo A&C
- Injection site reaction
- Nausea
- Headache
- Sleepiness
- Irritation
- Muscle pain
How to use Meningo A&C Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Meningo A&C Injection. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Meningo A&C Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Meningo A&C Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
SAFE
Meningo A&C Injection does not usually affect your ability to drive.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Meningo A&C Injection in patients with kidney disease. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Meningo A&C Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Meningo A&C Injection may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Meningo A&C Injection
₹395.0/Injection
Meningitis Act Injection
Sanofi India Ltd
₹381.25/injection
3% cheaper
Quadri Meningo Vaccine
Biomed Pharmaceuticals
₹1150/injection
191% costlier
Menomune Injection
Sanofi India Ltd
₹518.4/injection
31% costlier
Mencevax Acwy Vaccine
Glaxo SmithKline Pharmaceuticals Ltd
₹1050/injection
166% costlier
Mencevax Acwy Vaccine
Glaxo SmithKline Pharmaceuticals Ltd
₹1050/injection
166% costlier
Quick tips
- Meningo A&C Injection is used to prevent meningococcal disease.
- It is usually given by injection into the muscle of the upper arm.
- Your doctor will advise you if and when you should receive a booster dose.
- Immunocompromised individuals or persons suffering from functional or anatomic asplenia (including sickle cell disease) should get it.
- People travelling to US & Europe, Hajj (as meningococcal meningitis is more prevalent there) are advised to get vaccinated with Meningo A&C Injection.
Fact Box
Chemical Class
Vaccines
Habit Forming
No
Therapeutic Class
VACCINES
Action Class
Subunit (Purified antigen)
Patient concerns
FAQs
What is Meningo A&C Injection?
Meningo A&C Injection is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Meningo A&C Injection is approved for use in persons aged 2 months through 55 years.
Who should not take Meningo A&C Injection?
Meningo A&C Injection should not be given to patients with known allergy to any other ingredients of this medicine, or any other similar medicines in the past. Signs of an allergic reaction may include an itchy skin rash, shortness of breath and swelling of the face or tongue. If you have had an allergic reaction to any medicine earlier, inform your doctor about it.
Is a booster dose of Meningo A&C Injection needed?
Yes, a single booster dose of Meningo A&C Injection may be administered to individuals aged 15 through 55 years who may be at a continued risk of getting meningococcal disease, if at least 4 years have passed since a prior dose of it was given. If you have any doubts, consult your doctor.
How is Meningo A&C Injection given?
Meningo A&C Injection is given by a trained healthcare professional or a doctor only and should not be self-administered. Usually, it is given into the muscle of your upper arm, but it may also be given in the thigh muscle in children. Follow your doctor’s instructions carefully to get maximum benefit from Meningo A&C Injection.
Can Meningo A&C Injection cause meningococcal disease?
No. Meningo A&C Injection will not cause meningococcal disease. It just helps your body in producing antibodies against it, so that your body can fight the infection if you are exposed to it in future.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Sinha A, Singh S. Immunization and Immunodeficiency. In: Paul VK, Bagga A, editors. Ghai Essential Pediatrics. 8th ed. New Delhi: CBS Publisher's & Distributors Pvt Ltd.; 2013. p. 202.
- Vaccine.com. Meningococcal. [Accessed 04 Apr. 2019] (online) Available from:
Marketer details
Name: Sanofi India Ltd
Address: Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072
Country of origin: India
Lab tests offered by us
Related/Popular tests
95 people viewed this recentlyDISCONTINUED
We do not facilitate sale of this product at present